Growth Metrics

Palvella Therapeutics (PVLA) Non-cash Items (2014 - 2026)

Palvella Therapeutics (PVLA) reported Non-cash Items of $954970.0 for Q1 2026, up 91.54% year-over-year from $498578.0 in Q1 2025, and up 13.07% on a QoQ basis from $844567.0 in Q4 2025.

Palvella Therapeutics (PVLA) has 7 years of Non-cash Items data on file, last reported at $954970.0 in Q1 2026.

  • Quarterly Non-cash Items rose 91.54% year-over-year to $954970.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $954970.0 (up 91.54% YoY) and the FY2025 annual result came in at $844567.0, up 99.37% from the prior year.
  • Non-cash Items grew to $954970.0 in Q1 2026 per PVLA's latest filing, from $844567.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $20.5 million in Q3 2025 and bottomed at $423610.0 in Q4 2024.
  • The 3-year median for Non-cash Items is $710408.0 (2025), against an average of $4.0 million.
  • The widest annual swing landed in 2025, when Non-cash Items jumped 99.37%; it then soared 91.54% in 2026.
  • Tracing PVLA's Non-cash Items over 3 years: stood at $423610.0 in 2024, then jumped by 99.37% to $844567.0 in 2025, then advanced by 13.07% to $954970.0 in 2026.
  • Per Business Quant, the three latest PVLA Non-cash Items figures stand at $954970.0 (Q1 2026), $844567.0 (Q4 2025), and $20.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palvella Therapeutics 1.47 Bn 1.21 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 954,970.00
Mar 31, 2026 954,970.00
Dec 31, 2025 844,567.00
Dec 31, 2025 844,567.00
Sep 30, 2025 20.50 Mn
Sep 30, 2025 20.50 Mn
Jun 30, 2025 576,249.00
Jun 30, 2025 576,249.00
Mar 31, 2025 498,578.00
Mar 31, 2025 498,578.00
Dec 31, 2024 423,610.00
Dec 31, 2024 423,610.00
Dec 31, 2021 108,000.00
Dec 31, 2021 108,000.00
Dec 31, 2016 1.96 Mn
Dec 31, 2016 1.96 Mn
Dec 31, 2015 1.21 Mn
Dec 31, 2015 1.21 Mn
Sep 30, 2015 3.80 Mn
Sep 30, 2015 3.80 Mn
Jun 30, 2015 799,068.00
Jun 30, 2015 799,068.00
Mar 31, 2015 598,396.00
Mar 31, 2015 598,396.00
Dec 31, 2014 2.59 Mn
Dec 31, 2014 2.59 Mn